Johanna Bick, PhD; Tong Zhu, PhD; Catherine Stamoulis, PhD; et al.
free access
JAMA Pediatr. 2015;169(3):211-219. doi:10.1001/jamapediatrics.2014.3212
This randomized clinical trial finds that removal of children from a condition of severe neglect into a high-quality family environment supports white matter growth.
Fernando C. Barros, MD; Aris T. Papageorghiou, MD; Cesar G. Victora, MD; et al.
free access
JAMA Pediatr. 2015;169(3):220-229. doi:10.1001/jamapediatrics.2014.3040
This population-based, multiethnic, cross-sectional study identifies 12 preterm birth phenotypes associated with different patterns of neonatal outcomes.
Pierre-Yves Ancel, PhD; François Goffinet, PhD; and the EPIPAGE-2 Writing Group
free access
JAMA Pediatr. 2015;169(3):230-238. doi:10.1001/jamapediatrics.2014.3351
This national, prospective, population-based cohort study found substantial survival improvement in survival and a reduction in severe morbidity for newborns born at 25 through 31 weeks鈥� gestation.
Journal Club
Yvonne W. Wu, MD, MPH; Michael W. Kuzniewicz, MD, MPH; Andrea C. Wickremasinghe, MD; et al.
free access
JAMA Pediatr. 2015;169(3):239-246. doi:10.1001/jamapediatrics.2014.3036
This population-based double-cohort study finds an increased risk for cerebral palsy in infants with 2 or more risk factors for neurotoxicity and total serum bilirubin levels of more than 5 mg/dL above the exchange transfusion threshold (ETT).
M. Elsa Villarino, MD, MPH; Nigel A. Scott, MS; Stephen E. Weis, DO; et al.
free access
JAMA Pediatr. 2015;169(3):247-255. doi:10.1001/jamapediatrics.2014.3158
This randomized, open-label clinical trial shows that a combination of rifapentine and isoniazid was as effective as isoniazid alone in preventing tuberculosis in children aged 2 to 17 years, had a higher treatment completion rate, and was safe. See also the editorial by Marais.
Jonathan M. Ellen, MD; Lauren Greenberg, MPH; Nancy Willard, MS; et al.
free access
JAMA Pediatr. 2015;169(3):256-263. doi:10.1001/jamapediatrics.2014.3010
This serial cross-sectional survey determined that no structural changes, as measured in this study, were observed to be associated with a statistically significant reduction in risk behaviors.
Susanne E. Tanski, MD, MPH; Auden C. McClure, MD, MPH; Zhigang Li, PhD; et al.
free access
JAMA Pediatr. 2015;169(3):264-271. doi:10.1001/jamapediatrics.2014.3345
Surveys conducted in 2011 and 2013 and involving 2541 US adolescents 15 to 23 years of age at baseline examine the reach of television alcohol advertising and its effect on drinking among underage youth.
Brian K. Kit, MD, MPH; Elena Kuklina, MD; Margaret D. Carroll, MSPH; et al.
free access
JAMA Pediatr. 2015;169(3):272-279. doi:10.1001/jamapediatrics.2014.3216
This study uses the cross-sectional National Health and Nutrition Examination Survey to examine the prevalence of and trends in dyslipidemia and adverse blood pressure among US children and adolescents.
Antti Saari, MD; Samuli Harju, BM; Outi Mäkitie, MD, PhD; et al.
free access
online only
JAMA Pediatr. 2015;169(3):e1525. doi:10.1001/jamapediatrics.2015.25
This longitudinal retrospective study reports that acceptable screening accuracy can be achieved for celiac disease via the use of several growth monitoring parameters in combination, preferably using computerized screening algorithms integrated into an electronic health record system.
Rebecca S. Williams, MHS, PhD; Jason Derrick, MSW; Kurt M. Ribisl, PhD
free access
online only
JAMA Pediatr. 2015;169(3):e1563. doi:10.1001/jamapediatrics.2015.63
This study cross-sectional study reports that minors are easily able to purchase electronic cigarettes from the Internet because of an absence of age verification measures used by Internet electronic cigarette vendors and that federal law should require and enforce rigorous age verification for all electronic cigarette sales.